Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
Oncology Reports|December 29, 2015
Tyrosine kinase inhibitors target cancer stem cells in renal cell cancerAnna M Czarnecka, Wojciech Solarek, Anna Kornakiewicz, et al.
International Journal of Molecular Sciences|July 2, 2020
Targeted Therapy in Melanoma and Mechanisms of ResistanceAnna M Czarnecka, Ewa Bartnik, Michał Fiedorowicz, et al.
BMC Urology|September 7, 2014
Renal cell carcinoma with intramyocardial metastasesAnna M Czarnecka, Pawel Sobczuk, Fei Lian, et al.
Future Oncology (London, England)|June 20, 2014
Frontiers in clinical and molecular diagnostics and staging of metastatic clear cell renal cell carcinomaAnna M Czarnecka, Anna Kornakiewicz, Wojciech Kukwa, et al.
Future Oncology (London, England)|June 24, 2014
Development of chronic myeloid leukaemia in patients treated with anti-VEGF therapies for clear cell renal cell cancerAnna M Czarnecka, Sylwia Oborska, Piotr Rzepecki, et al.
Future Oncology (London, England)|March 12, 2015
Future perspectives for mTOR inhibitors in renal cell cancer treatmentAnna M Czarnecka, Anna Kornakiewicz, Fei Lian, et al.
Frontiers in Bioscience (Scholar Edition)|January 4, 2011
Vulvar cancer as a target for molecular medicineAleksandra Klemba, Wojciech Kukwa, Andrzej Semczuk, et al.
Otolaryngologia Polska = the Polish Otolaryngology|March 5, 2010
[Metabolic markers of the head and neck cancers--clinical applications and the biochemical background]Anna M Czarnecka, Wojciech Kukwa, Anna Scińska, et al.
Cell Stress & Chaperones|February 7, 2007
Heat shock protein 10 and signal transduction: a "capsula eburnea" of carcinogenesis?Anna M Czarnecka, Claudia Campanella, Giovanni Zummo, et al.
Future Oncology (London, England)|December 5, 2014
The role of prostaglandin E2 in renal cell cancer development: future implications for prognosis and therapyKatarzyna Kaminska, Cezary Szczylik, Fei Lian, et al.
Pageof 17